Mangoceuticals (MGRX) Total Non-Current Liabilities (2022 - 2026)
Mangoceuticals (MGRX) posted Total Non-Current Liabilities of $236965.0 for Q1 2026, up 1847.6% sequentially from $12167.0 in Q3 2024.
Mangoceuticals (MGRX) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
Mangoceuticals has reported Total Non-Current Liabilities for 4 years, with the latest figure at $236965.0 in Q1 2026.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $236965.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $236965.0 (changed N/A YoY) and the FY2023 annual result came in at $64961.0, down 49.52% from the prior year.
- Total Non-Current Liabilities improved to $236965.0 in Q1 2026 per MGRX's latest filing, from $12167.0 in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $236965.0 in Q1 2026 and troughed at $12167.0 in Q3 2024.
- A 4-year average of $90307.7 and a median of $81508.0 in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities plunged 49.52% in 2023, then slumped 85.07% in 2024.
- Over 4 years, Total Non-Current Liabilities stood at $128680.0 in 2022, then slumped by 49.52% to $64961.0 in 2023, then plunged by 81.27% to $12167.0 in 2024, then jumped by 1847.6% to $236965.0 in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $236965.0, $12167.0, and $30117.0 for Q1 2026, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 1.79 Bn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 3.85 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 1.12 Bn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 197.96 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 702.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 1.88 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 157.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 64.43 Mn |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | 250,906.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 250,906.00 |
| Mar 31, 2026 | 236,965.00 |
| Sep 30, 2024 | 12,167.00 |
| Jun 30, 2024 | 30,117.00 |
| Mar 31, 2024 | 47,713.00 |
| Dec 31, 2023 | 64,961.00 |
| Sep 30, 2023 | 81,508.00 |
| Jun 30, 2023 | 97,391.00 |
| Mar 31, 2023 | 113,267.00 |
| Dec 31, 2022 | 128,680.00 |